Cochlear
Cochlear is a leading global provider of implantable hearing solutions, known for its innovative cochlear implant systems. The company holds a strong market position due to its advanced technology and commitment to improving hearing outcomes. Cochlear's unique value lies in its continuous investment in research and development, ensuring cutting-edge solutions for hearing loss.
Short position
Cochlear (ASX:COH) has 2.14% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,400,880 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 7.65 percentage points. Its highest recorded short interest was 18.50% in July 2014. COH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Cochlear (COH) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $2.35Bvs $2.34B (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $147.3Mvs $388.9M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $2.25vs $5.94 (FY25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +0.2%FY
- EPS YoY
- −62.1%TTM
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 70.7%
- Operating margin
- 8.9%
- Net margin
- 6.3%
- FCF margin
- 11.8%
- ROE
- 8.0%
- ROA
- 5.4%
- FCF conversion
- 1.88×
- Net cash (excl. leases)
- $187.7M
- Net debt / EBITDA
- −0.6×
- Current ratio
- 2.2×
- Interest cover
- 15.8×
- Cash dividends paid / net profit
- 190.9%
- Market cap
- $8.40B
- P/E
- 57.0×
- P/B
- 4.8×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $2.35B | $2.34B | $2.24B | $1.94B |
| Gross profit | $1.66B | $1.73B | $1.67B | $1.45B |
| Operating income | $209.2M | $406.1M | $414.0M | $311.9M |
| EBITDA | $331.8M | $619.9M | $578.9M | $486.9M |
| EBIT | $227.1M | $529.5M | $494.0M | $406.0M |
| Interest expense | $13.2M | $11.0M | $9.2M | $9.4M |
| Pretax income | $213.9M | $518.5M | $484.8M | $396.6M |
| Tax | $66.6M | $129.6M | $128.0M | $96.0M |
| NPAT | $147.3M | $388.9M | $356.8M | $300.6M |
| Net interest income | −$3.0M | $700.0K | $9.8M | $7.1M |
| EPS basic | $2.25 | $5.94 | $5.45 | $4.57 |
| EPS diluted | $2.25 | $5.94 | $5.43 | $4.56 |
| Shares | 65.4M | 65.4M | 65.5M | 65.7M |
Financial reports
The company's own filings, newest first
- Annual ReportAnnual Report18 Aug 2026via asx_announcements
- Appendix 4EAnnual Results18 Aug 2026via asx_announcements
- Appendix 4D and Half Year Financial ReportHalf Year Results13 Feb 2026via asx_announcements
- Notice of Annual General Meeting & Proxy/Voting FormAgm Address19 Sep 2025via asx_announcements
- Annual Report (incl Sustainability reporting)Annual Report15 Aug 2025via asx_announcements
- Appendix 4EAnnual Results15 Aug 2025via asx_announcements
- Appendix 4D and Half Year Financial ReportHalf Year Results14 Feb 2025via asx_announcements
- COH Notice of Annual General Meeting & Proxy/Voting FormAgm Address18 Sep 2024via asx_announcements
- Annual Report (incl Sustainability reporting)Annual Report15 Aug 2024via asx_announcements
- Appendix 4EAnnual Results15 Aug 2024via asx_announcements
Showing 10 of 82 reports